Cystisk fibrose omfatter 30 000 mennesker bare i USA og det finnes ingen virkelig effektiv behandling. Mao; en gullgruve om man lykkes.
Et annet selskap som jobber mot det samme: https://carb-x.org/carb-x-news/carb-x-funds-microbion-to-develop-inhaled-drug-to-treat-cystic-fibrosis-related-lung-infections/
Kanskje Softox kan få støtte herfra? “CARB-X — Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator — is a global partnership launched in 2016 and dedicated to accelerate the development of new antibiotics that address the rising challenge of drug-resistant bacteria.”
“Microbion Corporation said that it has received a grant worth up to $11.5 million from global non-profit CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) and a grant worth up to $5.6 million from the Cystic Fibrosis Foundation (CFF) for pre-clinical and Phase 1 development of its pravibismane inhalation suspension for the treatment of pulmonary infections in cystic fibrosis patients. The FDA recently granted orphan drug designation to Microbion’s pravisbimane for that indication.”
Verdt å lese: http://www.mtoutlaw.com/bozemans-microbion-is-fighting-to-save-lives/